Ambu A/S: Interim report for Q2 2016/17 and for the period

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

May 2, 2017 at 4:00 AM 77

Ambu A/S: Interim report for Q2 2016/17 and for the period 1 October 2016 - 31 March 2017

Ambu raises its outlook for the year after a strong Q2 with organic growth of 14%, an EBIT margin of 19.7% and free cash flows of DKK 51m. "It is a pleasure to report growth of 14% for the quarter and 13% for the first half of the year as well as a significantly improved EBIT of 42%. It is clear that our single-use videoscopes are now widely recognised by doctors and hospitals as an intelligent choice, and it is positive that our core business is developing as expected, and that all our sales regions deliver impressive double-digit growth rates. We are optimistic about the year as a whole and therefore raise the outlook on all parameters: Growth, earnings and cash flows," says President and CEO Lars Marcher. Highlights · Revenue of DKK 613m was posted for Q2, representing growth of 14% in local currencies and 15% in Danish kroner. For the half-year, growth totalled 13% , when measured both in Danish kroner and in local currencies. · Anaesthesia contributed growth of 20% in Q2, while PMD (Patient Monitoring & Diagnostics) delivered growth of 4%, when measured in local currencies. For the half-year, growth was 19% for Anaesthesia and 2% for PMD . · Europe contributed growth of 16%, North America 10% and the rest of the world 19%. For the half-year, growth of 11% was posted for Europe , 11% for North America and 26% for the rest of the world . · Sales of single-use videoscopes continue to develop positively with sales in the quarter of 95,000 units. Sales volumes thus almost doubled compared to Q2 last year, up 90% on the first six months. · The gross margin for the quarter was 55.6% (52.4%), equating to an improvement of 3.2 percentage points. The gross margin for the half-year was 54.8% (52.5%). The improvement is due to a more profitable product mix and increased efficiency in production . · Total capacity costs for the quarter were DKK 220m (DKK 194m), corresponding to an increase of 13%. This corresponds to a 10% increase in capacity costs for the half-year . Exclusive of the costs of integrating ETView, the increase is 7%. · EBIT for the quarter was then DKK 121m (DKK 85m) with an EBIT margin of 19.7% (16.0%), corresponding to a 42% improvement. For the half-year, an EBIT of DKK 186m (DKK 131m) was posted, and an EBIT margin of 16.5% (13.2%). · Free cash flows before acquisitions of enterprises for the quarter were DKK 51m (DKK 31m), and for the half-year DKK 94m (DKK 34m). · The outlook for 2016/17 is raised . The outlook is now for organic growth of 12-14% against the previously announced outlook of 9-11%, an EBIT margin before special items of approx. 19% against the previously announced outlook of 18%, and free cash flows of DKK 250-275m against earlier expectations of approx. DKK 200m. Net interest-bearing debt is expected to be in the region of 1.5 x EBITDA rather than 1.6. In contrast to the outlook announced in the interim report for Q1, the integration costs in respect of ETView are now recognised in the revised outlook. A conference call is being held today, 2 May 2017, at 11.00 (CET). Please call the following number five minutes before the start of the conference: +45 3544 5580. The conference can be followed via www.ambu.com/webcastQ22017 and is held in English. The presentation can be downloaded immediately before the conference call via the same link. Contact Lars Marcher, President & CEO, tel. +45 5136 2490, email: lm@ambu.com

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...5804096e65

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Supply Maverick Simplifies Global Shipping Processes

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Jari Spirits Set to Shake Up U.S. Market After Big Wins

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Melissa Rivers Brings Her Wit Back to Emmys Carpet

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Modeling and Mental Health Join Forces for Wellness

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...